Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Archive
    • Subjects
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Archive
    • Subjects
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Source Data
Transparent Process
Open Access

GATA transcription factors, SOX17 and TFAP2C, drive the human germ-cell specification program

View ORCID ProfileYoji Kojima, View ORCID ProfileChika Yamashiro, Yusuke Murase, Yukihiro Yabuta, Ikuhiro Okamoto, Chizuru Iwatani, Hideaki Tsuchiya, Masataka Nakaya, View ORCID ProfileTomoyuki Tsukiyama, View ORCID ProfileTomonori Nakamura, Takuya Yamamoto, View ORCID ProfileMitinori Saitou
Yoji Kojima
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
3Center for iPS Cell Research and Application (CiRA), Kyoto University, Shogoin-Kawahara-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoji Kojima
Chika Yamashiro
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chika Yamashiro
Yusuke Murase
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukihiro Yabuta
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikuhiro Okamoto
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chizuru Iwatani
4Research Center for Animal Life Science, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Tsuchiya
4Research Center for Animal Life Science, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masataka Nakaya
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
4Research Center for Animal Life Science, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoyuki Tsukiyama
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
4Research Center for Animal Life Science, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomoyuki Tsukiyama
Tomonori Nakamura
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
7The Hakubi Center for Advanced Research, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomonori Nakamura
Takuya Yamamoto
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
3Center for iPS Cell Research and Application (CiRA), Kyoto University, Shogoin-Kawahara-cho, Kyoto, Japan
5AMED-CREST, AMED, Tokyo, Japan
6Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitinori Saitou
1Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
2Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Kyoto, Japan
3Center for iPS Cell Research and Application (CiRA), Kyoto University, Shogoin-Kawahara-cho, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mitinori Saitou
Published 19 February 2021. DOI: 10.26508/lsa.202000974
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. SOX17, TFAP2C, and BLIMP1 do not create human primordial germ-cell-like cells (hPGCLCs).

    (A) A schematic of the vectors used for Dox-inducible expression. The coding sequence of each gene was cloned in the designated position. D4Z4: D4Z4 macrosatellite repeat insulator; EF1α: promoter sequence of human EEF1A1; rtTA: reverse tetracycline trans-activator; IRES: internal ribosome entry site; Neo: Neomycin resistance gene; tetO: Tet operator sequence; rBGpA: rabbit β-globin polyadenylation signal; Puro/Hygro: resistance gene for puromycin/hygromycin. (B) Heat map representation of the expression levels of the indicated genes in the designated hiPSC clones stimulated with (+) or without (−) Dox (1.0 μg/ml) for 24 h. Two clones were examined for each transgene combination. To quantify the expression levels of the transgenes or endogenous genes by qRT-PCR, primer pairs for the rBGpA or 3′ untranslated regions were used, respectively, and the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). (C) The protocol for hPGCLC induction. iMeLC aggregates were induced for hPGCLC fate by bone morphogenetic protein 4 (BMP4) or Dox (1.0 μg/ml) in the presence of stem cell factor, EGF, and leukemia inhibitory factor. ActA: activin A; CHIR: CHIR99021. (D) Phase-contrast images of iMeLCs in the designated clones. No apparent morphological differences were seen among the clones. Representative images of at least two independent experiments are shown (shown in Fig 1F). Bar: 50 μm. (E) Bright-field and fluorescence (TFAP2C-EGFP [AG] and BLIMP1-tdTomato [BT]) images, and FACS analyses for BTAG expression in floating aggregates of the indicated transgene-expressing clones at day 4 of the indicated stimulation. (−): induction only with stem cell factor, EGF and leukemia inhibitory factor. Representative images of at least two independent experiments are shown (see Fig 1F). Bars, 200 μm. (F) Percentage of BT+AG+ cells of the indicated transgene-expressing clones with the indicated stimulations at day 2 (left) and day 4 (right). Dots represent values for each experiment and the bars represent their averages. The numbers of inductions performed are shown in parenthesis. (G, H) Expression dynamics of rBGpA (transgenes) and the indicated endogenous genes in the SOX17/TFAP2C (G) and SOX17/TFAP2C/BLIMP1 (H) clones induced by BMP4 (black) or Dox (red). d1: whole aggregates; d2/d4: BT+AG+ cells for induction by BMP4, BT+ cells for induction by Dox. For each gene, the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). (G, H) Three independent experiments with two SOX17/TFAP2C clones (G) and three SOX17/TFAP2C/BLIMP1 clones (H) were performed.

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1. SOX17, TFAP2C, and BLIMP1 do not create human primordial germ-cell-like cells.

    (A) The transgene expression levels in the designated hiPSC clones stimulated with (+) or without (−) Dox (1.0 μg/ml) for 24 h. Two clones were examined for each transgene combination. To quantify the transgene expression levels by qRT-PCR, primer pairs for the rabbit β-globin polyA sequence (rBGpA) or for the transgene coding sequences were used, and the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). The expression levels of SOX17, TFAP2C and BLIMP1 in d2 human primordial germ-cell–like cells (BT+AG+ cells) measured by primer pairs for detecting their 3′ untranslated regions are shown as references. n.d., not determined. (B) Western blot analysis of the expression of SOX17, BLIMP1, and TFAP2C in the SOX17/TFAP2C/BLIMP1 hiPSC clone without (−) or with (+) 1.0 μg/ml of Dox for 24 h. α-TUBULIN was used as loading control. (C, D) Expression dynamics of rBGpA (transgenes) and the indicated endogenous genes in the TFAP2C/BLIMP1 (C) and SOX17/BLIMP1 (D) clones induced by bone morphogenetic protein 4 (black) or Dox (red). d1: whole aggregates; d2/d4: BT+AG+ cells for induction by bone morphogenetic protein 4, BT+ cells for induction by Dox. For each gene, the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). The bars indicate the mean value of each time point. (C, D) Two independent experiments for the TFAP2C/BLIMP1 (C) and SOX17/BLIMP1 (D) clones were performed.

    Source data are available for this figure.

    Source Data for Figure S1[LSA-2020-00974_SdataFS1_FS4.pdf]

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Transcriptome analysis of the effects of the transcription factor expression.

    (A, B, C, D, E) Principal component analysis (PCA) of the effects of the transcription factor expression (see the Materials and Methods section for details). (A) The PCA plots of the cells (hiPSCs, iMeLCs, d1 whole aggregates, d2/d4/d6 BT+AG+ cells) derived from the parental clone (585B1 BTAG). The developmental progression is indicated by an arrow. (B, C, D, E) The PCA plots of the SOX17/TFAP2C/BLIMP1 (B), SOX17/TFAP2C (C), TFAP2C/BLIMP1 (D), and SOX17/BLIMP1 (E) clones (squares) are overlaid with those of the parental clone (circles with pale color). See Table S1 for the samples analyzed. The color coding is as indicated. (F) The numbers of the differentially expressed genes at d1/d2 between bone morphogenetic protein (BMP)– and Dox-stimulated cells of the SOX17/TFAP2C/BLIMP1 clones (P < 0.01 by Tukey–Kramer test, log2[RPM + 1] > 4 in cells with higher expression, log2[fold change: FC] >1 [up, pale yellow; down, pale blue] or 2 [up, yellow; down, blue]). d1: iMeLC whole aggregates; d2: BT+AG+ and BT+ cells for BMP- and Dox-stimulated cells, respectively. Note that the numbers of differentially expressed genes were smaller at d2, because the gene expression of the BT+ cells of the Dox-induced SOX17/TFAP2C/BLIMP1 clones was somewhat variable. (G, I) Gene ontology terms (blue) and KEGG pathways (pink) enriched in differentially expressed genes between BMP- and Dox-stimulated d1 SOX17/TFAP2C/BLIMP1 clone aggregates. (G, I) Representative genes up-regulated in BMP- (G) or Dox- (I) stimulations and P-values are shown. (F, H) Expression dynamics of the genes up-regulated at d1 (F) in BMP-stimulated (black) compared with Dox-stimulated (red) SOX17/TFAP2C/BLIMP1 clone-derived cells. The ranks of the genes ordered by the fold changes between BMP and Dox stimulation are shown. Note that TFAP2A, HAND1, HAPLN1, MSX2, and CDX2 were highly up-regulated in BMP-stimulated cells also at d2 (Fig S2B). See Table S1 for the samples analyzed. (E, H, J) Heat map representation of the expression of the genes in (H) in cynomolgus monkey fetal germ cells (early: embryonic day (E) 13-E17; late: E36-E51) (9, 18, 30, 31).

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2. Transcriptome analysis of the effects of the transcription factor expression.

    (A) (left) Principal component analysis of the expression of the 481 genes characterizing human primordial germ-cell–like cell specification shown in reference 13. Red (first quadrant): genes for PGCLC specification; cyan (fourth quadrant): genes for endoderm/mesoderm specification; yellow (second and third quadrants): genes for pluripotency (right). Heat map representation of the expression of the 481 genes in the parental hiPSCs, iMeLCs, bone morphogenetic protein (BMP)4-induced d1 whole aggregates, and d2/d4 BT+AG+ cells, and in TFAP2C/BLIMP1, SOX17/TFAP2C, SOX17/BLIMP1, SOX17/TFAP2C/BLIMP1 clone-derived, Dox-induced d2 BT+ cells. Representative genes are annotated, and the correlation coefficient values of each induction with the d4 BT+AG+ cells are shown. The color coding is as indicated. (B, C) Expression dynamics of the genes up-regulated in BMP-stimulated (black, BT+AG+) compared with Dox-stimulated (red, BT+) d2 cells (B) (Note that TFAP2A, HAND1, CDX2, HAPLN1, and MSX2 were highly up-regulated also at d1 [Fig 2H]) or those up-regulated in Dox-stimulated (red) compared with BMP-stimulated (black) SOX17/TFAP2C/BLIMP1 clone-derived d1 iMeLC aggregates (C). The bars indicate the mean value of each time point, and the ranks of the genes ordered by the fold changes between BMP- and Dox-stimulation are shown. See Table S1 for the samples analyzed. (D, E) Gene ontology terms (blue) and KEGG pathways (pink) enriched in differentially expressed genes between BMP and Dox- and Dox-stimulated SOX17/TFAP2C clone-derived cells at d2 (BMP and Dox: BT+AG+; Dox: BT+). (D, E) Representative genes up-regulated in BMP and Dox- (D) or Dox- (E) stimulations and P-values are shown.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. GATA3/2, SOX17, and TFAP2C generate human primordial germ-cell-like cells.

    (A) Expression dynamics of MSX2, GATA3, and GATA2 during bone morphogenetic protein (BMP)-driven human primordial germ-cell–like cell induction from the parental hiPSCs. Log2(RPM + 1) values are plotted and the bars indicate the mean value of each time point. See Table S1 for the samples analyzed. (B) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in floating aggregates of the MSX2/SOX17/TFAP2C clone induced by BMP4 or Dox at d4. Representative images of three independent experiments are shown. Bars, 200 μm. (C) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in floating aggregates of the GATA3/SOX17/TFAP2C clone (top) and GATA2/SOX17/TFAP2C clone (bottom) induced with or without Dox 1.0 μg/ml at d4. Representative images for 10 (GATA3/SOX17/TFAP2C) and six (GATA2/SOX17/TFAP2C) experiments are shown. Bars, 200 μm. (D) Expression of rBGpA (transgenes) and the indicated endogenous genes in BMP-induced parental clone-derived and Dox-induced GATA3/SOX17/TFAP2C clone- and GATA2/SOX17/TFAP2C clone-derived d4 BT+AG+ cells. Two replicates from independent experiments were analyzed. For each gene, the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). (E, F) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression at d4 in floating aggregates of the GATA3/SOX17/TFAP2C (E) and GATA2/SOX17/TFAP2C (F) clones induced by BMP4 or Dox with 0, 100, 500 nM of LDN193189. Representative images of at least two independent experiments are shown. Bars, 200 μm.

  • Figure S3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S3. GATA3/2, SOX17, and TFAP2C generate human primordial germ-cell-like cells.

    (A) Expression of GATA3 and GATA2 at d2 in bone morphogenetic protein (BMP) and Dox- or BMP-treated BT+ cells of the SOX17/TFAP2C/BLIMP1 clones, BMP and Dox-treated BT+ cells of the SOX17/TFAP2C clones, and BMP-treated BT+AG+ PGCLCs of the parental line. The transcriptome data were used and the values are shown in log2(RPM + 1). See Table S1 for the samples analyzed. (B) The transgene expression levels in the designated hiPSC clones stimulated with (+) or without (−) Dox (1.0 μg/ml) for 24 h. Two clones for MSX2/SOX17/TFAP2C and GATA3/SOX17/TFAP2C, one clone for GATA2/SOX17/TFAP2C, and four clones for GATA3/SOX17 expression were examined. To quantify the transgene expression levels by qRT-PCR, primer pairs for rabbit rBGpA or for the transgene coding sequences were used, and the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). (C) Heat map representation of the expression levels of the indicated genes in the designated hiPSC clones stimulated with (+) or without (−) Dox (1.0 μg/ml) for 24 h. To quantify the expression levels of the transgenes or endogenous genes, primer pairs for rBGpA or the 3′ untranslated regions were used, respectively, and the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). The color coding is as indicated. (D) Phase-contrast images of iMeLCs of the designated clones. No apparent morphological differences were seen among the clones. Representative images of at least two independent experiments are shown. Bars, 50 μm. (E) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in d2/d4 floating aggregates of the GATA3/SOX17/TFAP2C (left) and GATA3/SOX17 (right) clones induced by 0 (top) or 1.0 μg/ml (bottom) of Dox. Representative data for six (GATA3/SOX17/TFAP2C) and two (GATA3/SOX17) experiments are shown. Bars, 200 μm. (F) BT+AG+ cell induction efficiency (%) (left), BT+AG+ cell numbers per aggregate (middle), and total cell numbers per aggregate (right) of the GATA2/SOX17/TFAP2C and GATA3/SOX17/TFAP2C clones. Mean values (n = 3 for each line) are shown as red bars. (G) The principal component analysis plots of the cells (iMeLCs, Dox-induced d2/d4 BT+ cells) derived from the GATA3/SOX17 clone (squares), overlaid with the indicated cells derived from the parental clone (circles with pale color). See Table S1 for the samples analyzed. The color coding is as indicated.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. The transcription factor-induced BT+AG+ cells directly acquire human primordial germ-cell-like cell (hPGCLC) transcriptome.

    (A) The principal component analysis plots of the cells (iMeLCs, Dox-induced d2/d4/d6 BT+AG+ cells) derived from the GATA3/SOX17/TFAP2C clone (squares), overlaid with the indicated cells derived from the parental clone (circles with pale color). See Table S1 for the samples analyzed. The color coding is as indicated. (B) Heat map representation (color coding as indicated) of the expression of the 481 genes characterizing hPGCLC specification (13) (Fig S2) in the parental hiPSCs, iMeLCs, d1 whole aggregates, and d2/d4/d6 BT+AG+ cells and in Dox-induced, GATA3/SOX17/TFAP2C–derived d6 BT+AG+ cells. The correlation coefficient (0.926) between bone morphogenetic protein (BMP)– and Dox-induced d6 BT+AG+ cells is shown. The color coding in the left column is as follows: red, genes for PGCLC specification; cyan, genes for endoderm/mesoderm specification; yellow, genes for pluripotency. See Fig S2 for details. (C) The numbers of differentially expressed genes between BMP- and Dox-induced cells of the GATA3/SOX17/TFAP2C clone in d2/d4/d6 BT+AG+ cells (P < 0.01 by Tukey–Kramer test, log2[RPM + 1] > 4 in cells with higher expression, log2[fold change: FC] > 1 [up, pale yellow; down, pale blue] or 2 [up, yellow; down, blue]). (D, F) Gene ontology terms (blue) and KEGG pathways (pink) enriched in genes up-regulated in BMP-induced (D) and in Dox-induced (F) GATA3/SOX17/TFAP2C clone-derived d2 BT+AG+ cells. (E, G) Expression dynamics of the genes up-regulated in BMP-induced (E, the parental clone) or Dox-induced (G, the GATA3/SOX17/TFAP2C clone) d2 BT+AG+ cells during the respective induction processes (BMP: black; Dox: red). The bars indicate the mean value of each time point, and the rank of the gene ordered by the fold change is shown. See Table S1 for the samples analyzed. (H) Expression dynamics of GATA3 and GATA2 during BMP-induced hPGCLC induction from the parental (gray) and the indicated knockout hiPSCs (red) (d1: whole iMeLC aggregates; d2: EOMES−/−: whole aggregates; SOX17−/−: whole aggregates; TFAP2C−/−: BT+ cells; BLIMP1−/−: AG+ cells) (13). The bars indicate the mean value of each time point of each genotype. See Table S1 for the samples analyzed.

  • Figure S4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S4. Dose-dependent function of GATA transcription factors in human primordial germ-cell-like cell specification.

    (A) The CRISPR targets (left) and resulting mutations (right) for GATA3 (top), GATA2 (middle), and GATA2 in the GATA3−/− #40 clone (bottom). The same gRNA was used to create GATA2 mutants. (left) The amino acid sequences and the genomic structures (the exons: black boxes; introns: folded lines; un-translated regions: white boxes) of GATA3 and GATA2 are indicated, with the position of zinc finger DNA binding domain (orange) and the CRISPR target sites (red arrows). (right) The DNA sequences of both alleles for the indicated knockout lines are shown. Red and green letters indicate the positions of the gRNAs including the PAM sequences. del, deletion; ins, insertion. (B) Western blot analysis of GATA3 and GATA2 expression in TE-like cells induced from the GATA3−/−, GATA2−/−, GATA3−/−:GATA2+/−, and GATA3−/−:GATA2−/− clones, and in the GATA3−/−:GATA2−/−: GATA3 (rescued) clones cultured with or without 1.0 μg/ml of Dox for 24 h. α-TUBULIN was used as a loading control. (C) Phase-contrast images of iMeLCs in the designated clones. No apparent morphological differences were seen among the clones. Representative images of four (GATA3−/−) and two (GATA2−/−) independent experiments are shown. Bars, 50 μm. (D, E) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in d2/d4 floating aggregates of the GATA3−/−#17, #18, #30 (D) or GATA2−/− #6, #12 (E) clones induced by bone morphogenetic protein 4. Representative images of four (D) and two (E) independent experiments are shown. Bars, 200 μm. (F, G) The numbers of differentially expressed genes between the parental and GATA3−/− (E) or GATA2−/− (F) clones in iMeLCs (iM), d2/d4/d6 BT+AG+ cells (P < 0.01 by Tukey–Kramer test, log2[RPM + 1] > 4 in cells with higher expression, log2[fold change: FC] > 1 [up, pale yellow; down, pale blue] or 2 [up, yellow; down, blue]). (H) Phase-contrast images of the TE-like cells induced from the designated clones. The GATA3−/−:GATA2+/− #5-1 clone exhibited a cobblestone-like epithelial morphology similar to TE, whereas the GATA3−/−:GATA2−/− #5-10 clone failed to show TE-like differentiation and exhibited a mesenchymal morphology. Bars, 200 μm. (I) Phase-contrast images of iMeLCs in the designated clones. No apparent morphological differences were seen among the clones. Representative images of at least two independent experiments are shown (indicated in Fig 5F). Bars, 50 μm.

    Source data are available for this figure.

    Source Data for Figure S4[LSA-2020-00974_SdataFS1_FS4.pdf]

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5. Dose-dependent function of GATA transcription factors in human primordial germ-cell-like cell specification.

    (A) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in floating aggregates of the GATA3−/−, GATA2−/−, and parental clones induced by bone morphogenetic protein 4 (BMP4) at d2/d4. Representative images of at least two independent experiments are shown (indicated in Fig 5F). Bars, 200 μm. (B) Expression dynamics of the indicated genes during human primordial germ-cell–like cell induction (iMeLCs, d2/d4 BT+AG+ cells) by BMP4 from the parental (black), GATA3−/− (red), and GATA2−/− (blue) clones. For each gene, the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0). The bars indicate the mean value of each time point of each genotype. Replicate numbers: GATA2−/−: 3; GATA3−/−: 4 for iMeLCs and 8 for d2/d4 BT+AG+ cells; parental clone: 2. (C, D) The principal component analysis plots of the cells (iMeLCs, d2/d4/d6 BT+AG+ cells) derived from the GATA3−/− (C) and GATA2−/− (D) clones (squares), overlaid with the indicated cells derived from the parental clone (circles with pale colors). See Table S1 for the samples analyzed. The color coding is as indicated. (E) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in floating aggregates of the GATA3−/−; GATA2+/− and GATA3−/−; GATA2−/− clones induced by BMP4 at d4. Representative images of at least two independent experiments are shown (indicated in Fig 5F). Bars, 200 μm. (F) The percentages of BT+AG+ cell induction from the indicated genotypes at d4. The replicate numbers and the P-values (t test) are as indicated. The inductions were performed side by side. Typically, the efficiency for BT+AG+ cell induction from parental hiPSCs varies to this extent (20%∼60%) (9, 13, 26). (G) A scheme for GATA3 expression in the GATA3−/−; GATA2−/−; GATA3 clone. (H) Bright-field and fluorescence (AG/BT) images, and FACS analyses for BTAG expression in floating aggregates of the GATA3−/−; GATA2−/−; GATA3 clone upon induction with BMP4 and 0, 0.5, and 1.0 μg/ml of Dox at d4. Representative images of at least two independent experiments are shown (indicated in Fig 5F). Bars, 200 μm. (I) The percentages of BT+AG+ cell induction at d4 (two replicates) from the GATA3−/−; GATA2−/−; GATA3 clone induced with BMP4 and 0, 0.5, and 1.0 μg/ml of Dox treatment. (J) Expression of the indicated genes in d4 BT+AG+ cells induced from the parental (with BMP4, red) or GATA3−/−; GATA2−/−; GATA3 (with BMP4 and Dox, green) clones (two replicates). For each gene, the ΔCt was calculated from the average Ct value of two housekeeping genes, RPLP0 and PPIA (set as 0).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6. GATA3 expression in post-implantation cynomolgus monkey embryos.

    (A, B, C) Immunofluorescence analysis of GATA3 (magenta), SOX17 (cyan), and TFAP2C (green) expression (merged with DAPI) in cynomolgus monkey embryos at E12 (A), E13 (B) and E15 (C). For E15 (C), the boxed area (top) is magnified (bottom). Orange arrowheads indicate triple-positive PGCs, whereas white arrowheads indicate SOX17/TFAP2C+ but GATA3− cells. Note that there was no signal in the epiblast (asterisk). (D) Representative images of the samples shown in (D) are presented. Bars, 50 μm. (D) The numbers of embryos (E12, E13, and E15), total sections, and sections with PGCs (SOX17+TFAP2C+ cells), PGCs, and GATA3+ PGCs analyzed/detected in this study. (E) Heat map representation of the expression of key genes in the indicated cell types of the post-implantation cy embryos (30). The colored bars on top indicate cell types (top) and embryonic days (bottom), respectively. The color coding is as indicated. Post-paTE, PostE-EPI, post-implantation early epiblast; G1, gastrulating cells, group 1; postL-EPI, post-implantation late epiblast; G2a/G2b, gastrulating cells, group 2a/2b; VE/YE, visceral endoderm/yolk sac endoderm; EXMC, extraembryonic mesenchyme; ePGC, early PGC.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7. Transcription factor-induced BT+AG+ cells differentiate into oogonia/gonocytes in xrOvaries.

    (A) A scheme for xrOvary culture (10, 11) with Dox-induced GATA3/SOX17/TFAP2C clone-derived d6 BT+AG+ cells. (B) Immunofluorescence analysis of TFAP2C (green), human mitochondria antigen (magenta), and DDX4 (cyan) expression (merged with DAPI) on aggregation day (ag) 77 xrOvaries. In two independent experiments, 28 and 23 TFAP2C/DDX4-expressing cells/7 sections, respectively, were detected. Bars, 50 μm. (C) The principal component analysis plots of the transcriptome of the GATA3/SOX17/TFAP2C clone-derived d6 BT+AG+ cells, d6ag77 BT+AG+ cells, and the parent clone-derived bone morphogenetic protein-induced d6ag77 BT+AG+ cells (see Table S1) with the relevant cell types during in vitro oogonia/gonocyte differentiation reported in reference 10, in which 585B1 BTAG hiPSCs (XY) and 1390G3 AGVT (AG; DDX4 [also known as VASA]-tdTomato [VT]) hiPSCs (XX) were used as starting materials. Numbers following “ag” indicate the culture days in xrOvaries. For the AGVT cells, ag77 and 120 AG+VT− (AG), AG+VT+ (AGVT) or AG−VT+ (VT) were used for analysis. (D) Expression dynamics of the key genes in GATA3/SOX17/TFAP2C clone-derived d6 BT+AG+ cells, and d6ag77 BT+AG+ cells (n = 2, red circles) (see Table S1), overlaid with those in the relevant cell types during the in vitro oogonia/gonocyte differentiation reported in reference 10. (E) Scatter-plot comparisons, combined with histogram representations (top and right of scatter plots), of the genome-wide 5 mC levels (genome-wide 2-kb windows) between the indicated cell types. (F) Violin-plot representation of the genome-wide 5 mC levels determined by whole-genome bisulfite sequence analysis in the cell types indicated. The mean levels are indicated by red bars. (G, H) Heat map representation showing the 5 mC levels in the indicated genomic elements on the autosomes (G) and in the differentially methylated regions of the indicated imprinted genes (H) in the indicated cells. HCP/ICP/LCP, high/intermediate/low-CpG promoters. The color coding is as indicated. (I) A model of the transcription factor circuitry driving human primordial germ-cell like cell specification.

  • Figure S5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S5. Transcription factor-induced BT+AG+ cells differentiate into oogonia/gonocytes in xrOvaries.

    Heat map representation of the expression of the 453 genes (the cluster 1–5 genes) characterizing the in vitro oogonia/gonocyte differentiation process reported in reference 10 in the GATA3/SOX17/TFAP2C-derived d6ag77 BT+AG+ cells and the parent clone-derived bone morphogenetic protein–induced d6ag77 BT+AG+ cells, in comparison with those in the relevant cell types in reference 10 and in human fetal germ cells reported in reference 47, as indicated. Representative genes are annotated, and gene ontology-term enrichments in each cluster and key genes are listed. ag, aggregation culture days; VT: DDX4 (also known as VASA)-tdTomato; hGC, human germ cells; M, male; F, female; W, developmental week. Numbers following the indications of cellular states denote replicate numbers. The color coding is as indicated.

Tables

  • Figures
  • Supplementary Materials
  • Reagents and tools table

    Reagent/resourceReference or sourceIdentifier or catalog number
    Experimental models
     BTAG (BLIMP1-tdTomato and TFAP2C-eGFP knockin reporters in the 585B1 hiPSCs)Sasaki et al (2015).N/A
     BTAG; SOX17 OE#1This studyN/A
     BTAG; SOX17 OE#2This studyN/A
     BTAG; TFAP2C OE#1This studyN/A
     BTAG; TFAP2C OE#3This studyN/A
     BTAG; SOX17+BLIMP1 OE#9This studyN/A
     BTAG; SOX17+BLIMP1 OE#15This studyN/A
     BTAG; TFAP2C+BLIMP1 OE#2This studyN/A
     BTAG; TFAP2C+BLIMP1 OE#15This studyN/A
     BTAG; SOX17+TFAP2C OE#2This studyN/A
     BTAG; SOX17+TFAP2C OE#11This studyN/A
     BTAG; SOX17+TFAP2C OE#28This studyN/A
     BTAG; SOX17+TFAP2C+BLIMP1 OE#4This studyN/A
     BTAG; SOX17+TFAP2C+BLIMP1 OE#9This studyN/A
     BTAG; SOX17+TFAP2C+BLIMP1 OE#22This studyN/A
     BTAG; SOX17+TFAP2C+BLIMP1 OE#28This studyN/A
     BTAG; SOX17+TFAP2C+BLIMP1 OE#31This studyN/A
     BTAG; SOX17+TFAP2C+MSX2 OE#7This studyN/A
     BTAG; SOX17+TFAP2C+MSX2 OE#9This studyN/A
     BTAG; GATA3+SOX17+TFAP2C OE#1This studyN/A
     BTAG; GATA3+SOX17+TFAP2C OE#5This studyN/A
     BTAG; GATA2+SOX17+TFAP2C OE#29This studyN/A
     BTAG; GATA2−/− #1This studyN/A
     BTAG; GATA2−/− #6This studyN/A
     BTAG; GATA2−/− #12This studyN/A
     BTAG; GATA3−/− #17This studyN/A
     BTAG; GATA3−/− #18This studyN/A
     BTAG; GATA3−/− #30This studyN/A
     BTAG; GATA3−/− #40This studyN/A
     BTAG; HAND1−/− #6This studyN/A
     BTAG; GATA3−/−; GATA2+/− #5-1This studyN/A
     BTAG; GATA3−/−; GATA2−/− #5-10This studyN/A
     BTAG; GATA3−/−; GATA2−/−; GATA3 OE #19This studyN/A
    Recombinant DNA
     pX335-U6-Chimeric BB-CBh-hSpCas9n (D10A)AddgeneCat. no. 42335
    Antibodies
     Goat anti-SOX17R&D SystemsAF1924; RRID: AB_355060
     Mouse anti-TFAP2CSanta Cruzsc-12762; RRID: AB_667770
     Mouse anti-BLIMP1R&D SystemsMAB36081; RRID: AB_10718104
     Mouse anti-GATA3BIOCAREACR405A; RRID: AB_10895444
     Rabbit anti-GATA3Cell SignalingCST5852S; RRID:AB_10835690
     Rabbit anti-GATA2NovusNBP82581; RRID:AB_11026191
     Rabbit anti-GATA2Santa Cruzsc9008; RRID:AB_2294456
     Mouse anti-human mitochondriaMerck MilliporeMAB1273; RRID:AB_94052
     Goat anti-DDX4R&D SystemsAF2030; RRID:AB_2277369
     Mouse IgG – HRP conjugatedSigma-AldrichA5906; RRID: AB_258264
     Mouse anti-α TubulinSigma-AldrichT9026; RRID: AB_477593
     Mouse IgG – HRP conjugatedSigma-AldrichA5906; RRID: AB_258264
     Rabbit IgG – HRP conjugatedSigma-AldrichA6154; RRID: AB_258284
     Goat IgG – HRP conjugatedSigma-AldrichA5420; RRID: AB_258242
     SSEA1 (CD15) microbeads for human and mouseMiltenyi Biotec130-094+530
     CD31 microbeads for mouseMiltenyi Biotec130-097-418
    Oligonucleotides and sequence-based reagents
     qRT-PCR primersThis studyTable S3
    Chemicals, enzymes and other reagents
     StemFit AK03NAjinomotoN/A
     iMatrix-511Nippi
     PuromycinThermo Fisher ScientificA1113803
     G418, GeneticinThermo Fisher Scientific#10131035
     Hygromycin BThermo Fisher Scientific#10131035
     DoxycyclineTakara-ClontechZ1311N
     FibronectinMilliporeFC010
     GMEMThermo Fisher Scientific#11710035
     Knockout serum replacementThermo Fisher ScientificA3181502
     Activin APeprotech120-14E
     CHIR99021TOCRIS#4423
     Y27632FujiFilm030-24021
     BMP4R&D Systems314-BP
     SCFR&D Systems255-SC
     EGFR&D Systems236-EG
     LIFMilliporeLIF1010
     LDN193189StemGent04-0074
     GlutamaxThermo Fisher Scientific35050-061
     HEPESThermo Fisher Scientific15630-106
     α-Minimum Essential MediumThermo Fisher Scientific32571-036
     L-ascorbic acidSigma-AldrichA4403
    Software
     FACSDiva SoftwareBD BiosciencesN/A
     DAVID (v6.8; GO analysis)https://david.ncifcrf.gov/N/A
     FV10-ASWOlympusN/A
     R (v3.6.0; PCA, DEG, and graphs)https://www.R-project.orgN/A
     Bowtie2 v2.2.7http://bowtie-bio.sourceforge.net/bowtie2/index.shtmlN/A
     TopHat v2.1.0https://ccb.jhu.edu/software/tophat/index.shtmlN/A
     HTSeq v0.9.1https://htseq.readthedocs.io/en/master/overview.htmlN/A
     ImageJ/FijiFiji.scN/A
     Trim_galore v0.6.3https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/N/A
     cutadapt v118http://cutadapt.readthedocs.io/en/stable/guide.htmlN/A
     Bismark v0.22.1https://www.bioinformatics.babraham.ac.uk/projects/bismark/N/A
     SAMtools v1.9http://samtools.source-forge.netN/A
    Other
     pGEM-T Easy KitPromegaA3600
     Gateway LR Clonase Enzyme MixThermo Fisher Scientific#11791043
     v-bottom 96-well plateGreiner#651970
     RNeasy Micro KitQIAGEN#74004
     NucleoSpin RNA XSMacherey-Nagel#740902
     Qubit RNA HS assay kitThermo Fisher ScientificQ32855
     PowerSYBR Green PCR Master MixThermo Fisher Scientific#4367659
     Qubit dsDNA HS assay kitThermo Fisher ScientificQ32851
     Protein Quantification AssayMacherey-Nagel#740967
     ECL Western Blotting Detection ReagentGE Healthcare Life SciencesRPN2106
     EZ DNA Methylation-Gold KitZymogenD5005
     DP72OlympusN/A
     FV1000-IX81 confocal microscope systemOlympusN/A
     CFX384 Touch Real-Time PCR detection systemBio-Rad LaboratoriesN/A
     NextSeq500/550IlluminaN/A
     Hiseq2500IlluminaN/A

Supplementary Materials

  • Figures
  • Tables
  • Table S1 List of cell types used for transcriptome analysis.

  • Table S2 List of differentially expressed genes between relevant cell types generated in this study.

  • Table S3 Primers used in this study.

PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
GATA transcription factors, SOX17 and TFAP2C, drive the human germ-cell specification program
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Induction of human germ-cell fate
Yoji Kojima, Chika Yamashiro, Yusuke Murase, Yukihiro Yabuta, Ikuhiro Okamoto, Chizuru Iwatani, Hideaki Tsuchiya, Masataka Nakaya, Tomoyuki Tsukiyama, Tomonori Nakamura, Takuya Yamamoto, Mitinori Saitou
Life Science Alliance Feb 2021, 4 (5) e202000974; DOI: 10.26508/lsa.202000974

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Induction of human germ-cell fate
Yoji Kojima, Chika Yamashiro, Yusuke Murase, Yukihiro Yabuta, Ikuhiro Okamoto, Chizuru Iwatani, Hideaki Tsuchiya, Masataka Nakaya, Tomoyuki Tsukiyama, Tomonori Nakamura, Takuya Yamamoto, Mitinori Saitou
Life Science Alliance Feb 2021, 4 (5) e202000974; DOI: 10.26508/lsa.202000974
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 4, No. 5
May 2021
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Data and Code Availability
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Development

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2021 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.